Lv2
156 积分 2024-01-29 加入
LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery
19天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
20天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
20天前
已完结
Toward precision immunotherapy: In vivo gene editing of T, NK, and myeloid cells
24天前
已关闭
Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease
24天前
已完结
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
24天前
已完结
In vivo nano-engineering T cells for CAR-T therapy
24天前
已完结
In vivo CAR-T cell engineering in refractory SLE
24天前
已完结
In vivo CAR T cells gain traction, with AbbVie’s US$2.1 billion acquisition of Capstan Therapeutics
24天前
已完结
Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
24天前
已完结
皖公网安备34019202002308
